FDA Class II · Drug · July 8, 2026
Lidocaine HCl Injection USP recall — Asclemed USA Inc.
Lack of Assurance of Sterility
Official ID D-0659-2026 · Official record ↗
Asclemed USA recalls
3 recent recalls on record for Asclemed USA in CPSC, NHTSA, and FDA data as of July 24, 2026 at 1:09 AM UTC.
Models with recalls
All Asclemed USA recalls
FDA Class II · Drug · July 8, 2026
Accucaine recall — Asclemed USA Inc.
Lack of Assurance of Sterility
Official ID D-0658-2026 · Official record ↗
FDA Class II · Drug · June 10, 2026
Duloxetine DR Capsules recall — Asclemed USA Inc.
CGMP Deviations; presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the FDA acceptable intake limit.
Official ID D-0555-2026 · Official record ↗
Verify with the official sources:
- CPSC — consumer products ↗ (aggregated here)
- NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
- FDA — food, drugs, medical devices ↗ (aggregated here)
- USDA FSIS — meat, poultry & egg products ↗ (not yet aggregated here)
- Recalls.gov — the U.S. government’s all-agency portal ↗
Found something wrong or missing? Report a data error.
Compiled from official public-domain government data. Last checked July 24, 2026 at 1:09 AM UTC.